RASP (Actavia Life Sciences) Payments of Debt: $-0.03 Mil (TTM As of Mar. 2024)


What is Actavia Life Sciences Payments of Debt?

Actavia Life Sciences RASP -87.50% Payments of Debt is $-0.03 Mil as of Mar. 2024.

Actavia Life Sciences's Payments of Debt for the three months ended in Mar. 2024 was $0.00 Mil.

Actavia Life Sciences's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.03 Mil.

Actavia Life Sciences Payments of Debt Related Terms

Actavia Life Sciences Payments of Debt Historical Data

* Premium members only.

The historical data trend for Actavia Life Sciences's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actavia Life Sciences Payments of Debt Chart

Actavia Life Sciences Annual Data
Trend Jun14 Jun15 Jun16 Mar17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.29 -0.07 -0.07

Actavia Life Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.01 -0.01 0.00

Actavia Life Sciences Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-0.03 Mil mean?
Actavia Life Sciences (RASP) has a Payments of Debt of $-0.03 Mil as of Mar. 2024. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Actavia Life Sciences and its competitors.
Is Actavia Life Sciences' Payments of Debt too high?
Actavia Life Sciences' current Payments of Debt is $-0.03 Mil.
How does Actavia Life Sciences' Payments of Debt compare to BWV and FNCH?
Actavia Life Sciences' Payments of Debt of $-0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Actavia Life Sciences and its competitors. Actavia Life Sciences's current Payments of Debt is $-0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Actavia Life Sciences stock overvalued right now?
Actavia Life Sciences (RASP) has a current Payments of Debt of $-0.03 Mil. The current Payments of Debt is $-0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Actavia Life Sciences (RASP), the current Payments of Debt is $-0.03 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Actavia Life Sciences Business Description

Address 5 Penn Plaza, No.1954, 19th Floor, New York, NY, USA, 10001
Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.